US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

13.81

+0.75005.74%

Post-market: 13.810.00000.00%19:30 EDT

Volume:197.97K

Turnover:2.71M

Market Cap:203.36M

PE:-1.40

High:14.06

Open:13.28

Low:13.17

Close:13.06

52wk High:55.89

52wk Low:5.20

Shares:14.73M

Float Shares:10.47M

Volume Ratio:1.78

T/O Rate:1.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.8800

EPS(LYR):-12.4806

ROE:-97.69%

ROA:-27.95%

PB:1.97

PE(LYR):-1.11

Loading ...

Overview Company News Filings

Analysts Have Conflicting Sentiments on These Healthcare Companies: CareCloud (CCLD) and Korro Bio (KRRO)

Korro Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Korro Bio Q1 EPS $(1.69) Beats $(2.17) Estimate

Benzinga Earnings

Korro Bio posts corporate presentation on RNA-editing genetic medicines pipeline

Korro Bio Q1 FY26 net loss narrows to $19.6 million; R&D expenses fall to $12.9 million

Korro Bio Inc Qtrly EPS $-1.69

THOMSON REUTERS

Korro Bio Inc - Reports Cash, Cash Equivalents and Marketable Securities of $157.1 Mln as of March 31, 2026

THOMSON REUTERS

Korro Bio Inc - Reports No Collaboration Revenue for Q1 2026

THOMSON REUTERS

Korro Bio Inc - Expects Cash Position to Fund Operations Into Second Half of 2028

THOMSON REUTERS

Korro Bio participates in HCW BioConnect Nasdaq investor conference fireside chat

Korro Bio Inc expected to post a loss of $1.84 a share - Earnings Preview

Korro Bio to present preclinical KRRO-121 hyperammonemia data at ASGCT meeting

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

THOMSON REUTERS

Korro Bio announces annual shareholder meeting notice

BRIEF-Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Korro Bio grants new-hire inducement option for 15,000 shares at $13.46 each

Korro Bio initial beneficial ownership filing shows Lynx1 Capital Management as 10% owner

Korro Bio Inc. publishes corporate presentation on RNA editing genetic medicines and pipeline milestones

Korro Bio Inc reports results for the quarter ended December 31 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/KRRO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":13.81,"timestamp":1789156800000,"preClose":13.06,"halted":0,"volume":197974,"hourTrading":{"tag":"盘后","latestPrice":13.81,"preClose":13.81,"latestTime":"19:30 EDT","volume":1382,"amount":19089.41,"timestamp":1789169407635,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.05742725880551301,"floatShares":10470900,"shares":14725646,"eps":-9.88,"marketStatus":"Market Closed","change":0.75,"latestTime":"09-11 16:00:00 EDT","open":13.28,"high":14.06,"low":13.1738,"amount":2709684.7880760003,"amplitude":0.067856,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.88,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1570075200000,"exchange":"NASDAQ","adjPreClose":13.06,"postHourTrading":{"tag":"盘后","latestPrice":13.81,"preClose":13.81,"latestTime":"19:30 EDT","volume":1382,"amount":19089.41,"timestamp":1789169407635,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.7753159198034936,"impliedVol":1.8456,"impliedVolPercentile":0.9375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","floatShares":10470900,"roa":"-27.95%","roe":"-97.69%","lyrEps":-12.480572,"volumeRatio":1.7753159198034936,"shares":14725646,"dividePrice":0,"high":14.06,"amplitude":0.067856,"preClose":13.06,"low":13.1738,"week52Low":5.2044,"pbRate":"1.97","psRate":"85.37","week52High":55.89,"institutionHeld":0,"latestPrice":13.81,"eps":-9.88,"divideRate":0,"volume":197974,"delay":0,"ttmEps":-9.88,"open":13.28,"prevYearClose":8.01,"prevWeekClose":12.24,"prevMonthClose":12.49,"prevQuarterClose":13.18,"fiveDayClose":11.62,"twentyDayClose":13.29,"sixtyDayClose":10.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"KRRO","fiscalQuarterEnding":"2026/06","expectedEps":-1.54,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-1.07},{"market":"US","date":"2026-05-07","symbol":"KRRO","fiscalQuarterEnding":"2026/03","expectedEps":-1.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.69},{"market":"US","date":"2026-03-12","symbol":"KRRO","fiscalQuarterEnding":"2025/12","expectedEps":-1.93,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-5.32},{"market":"US","date":"2025-11-12","symbol":"KRRO","fiscalQuarterEnding":"2025/09","expectedEps":-2.61,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.92},{"market":"US","date":"2025-08-12","symbol":"KRRO","fiscalQuarterEnding":"2025/06","expectedEps":-2.54,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-2.74}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.6667,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1786420800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KRRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KRRO","date":"2026-09-11","current":-1.397773,"percent":0.615385,"low":-8.894386,"twenty":-5.468413,"median":-3.15468,"eighty":-1.430777,"high":-0.562373,"avg":-3.377155,"sd":2.052149,"marketCap":192316936},"quantilePoints":[{"date":"2023-11-10","current":-4.581336,"twenty":-4.600294,"median":-4.593185,"eighty":-4.586076,"marketCap":328848276},{"date":"2023-11-17","current":-4.545683,"twenty":-4.815324,"median":-4.662668,"eighty":-4.586076,"marketCap":326289146},{"date":"2023-11-24","current":-4.263806,"twenty":-4.730727,"median":-4.581336,"eighty":-4.305029,"marketCap":306056020},{"date":"2023-12-01","current":-4.669353,"twenty":-4.669353,"median":-4.511145,"eighty":-4.263806,"marketCap":335166130},{"date":"2023-12-08","current":-5.29327,"twenty":-5.459276,"median":-4.605034,"eighty":-4.305029,"marketCap":379950915},{"date":"2023-12-15","current":-5.927214,"twenty":-5.596315,"median":-4.70004,"eighty":-4.344024,"marketCap":425455455},{"date":"2023-12-22","current":-5.775692,"twenty":-5.775692,"median":-5.29327,"eighty":-4.447639,"marketCap":414579150},{"date":"2023-12-29","current":-5.477103,"twenty":-5.763659,"median":-5.468189,"eighty":-4.46502,"marketCap":393146432},{"date":"2024-01-05","current":-5.57069,"twenty":-5.744941,"median":-5.477103,"eighty":-4.490422,"marketCap":399864150},{"date":"2024-01-12","current":-4.878811,"twenty":-5.700822,"median":-5.48323,"eighty":-4.552814,"marketCap":350201022},{"date":"2024-01-19","current":-4.570194,"twenty":-5.695474,"median":-5.467075,"eighty":-4.570194,"marketCap":328048548},{"date":"2024-01-26","current":-5.793518,"twenty":-5.702159,"median":-5.459276,"eighty":-4.579107,"marketCap":415858716},{"date":"2024-02-02","current":-5.903818,"twenty":-5.702159,"median":-5.475988,"eighty":-4.581336,"marketCap":423776026},{"date":"2024-02-09","current":-6.542219,"twenty":-5.793518,"median":-5.496043,"eighty":-4.605034,"marketCap":469600457},{"date":"2024-02-16","current":-6.005204,"twenty":-5.995177,"median":-5.561777,"eighty":-4.662668,"marketCap":431053553},{"date":"2024-02-23","current":-5.637539,"twenty":-6.009661,"median":-5.57459,"eighty":-4.668016,"marketCap":404662519},{"date":"2024-03-01","current":-5.381287,"twenty":-5.997182,"median":-5.57069,"eighty":-4.718452,"marketCap":386268768},{"date":"2024-03-08","current":-5.46819,"twenty":-5.954177,"median":-5.56679,"eighty":-4.734215,"marketCap":392506649},{"date":"2024-03-15","current":-6.597926,"twenty":-6.029715,"median":-5.57069,"eighty":-4.778761,"marketCap":473599099},{"date":"2024-03-22","current":-7.241897,"twenty":-6.148928,"median":-5.582946,"eighty":-4.827114,"marketCap":519823395},{"date":"2024-03-28","current":-8.749112,"twenty":-6.225581,"median":-5.594644,"eighty":-4.85118,"marketCap":710182879},{"date":"2024-04-05","current":-7.056213,"twenty":-6.445289,"median":-5.625283,"eighty":-4.87168,"marketCap":572766944},{"date":"2024-04-12","current":-7.760846,"twenty":-6.653602,"median":-5.643524,"eighty":-4.982426,"marketCap":629963419},{"date":"2024-04-19","current":-6.599635,"twenty":-6.850878,"median":-5.695474,"eighty":-5.142416,"marketCap":535705553},{"date":"2024-04-26","current":-6.686174,"twenty":-6.869775,"median":-5.765664,"eighty":-5.203025,"marketCap":542730135},{"date":"2024-05-03","current":-6.650761,"twenty":-6.964451,"median":-5.793518,"eighty":-5.219737,"marketCap":539855604},{"date":"2024-05-10","current":-6.269217,"twenty":-6.920952,"median":-5.915516,"eighty":-5.240905,"marketCap":508884843},{"date":"2024-05-17","current":-5.859151,"twenty":-6.869775,"median":-5.859151,"eighty":-5.274998,"marketCap":475317730},{"date":"2024-05-24","current":-5.495668,"twenty":-6.850878,"median":-5.84806,"eighty":-5.34608,"marketCap":445830598},{"date":"2024-05-31","current":-5.743893,"twenty":-6.8128,"median":-5.816278,"eighty":-5.412483,"marketCap":465967596},{"date":"2024-06-07","current":-5.114065,"twenty":-6.734223,"median":-5.793518,"eighty":-5.389162,"marketCap":414873438},{"date":"2024-06-14","current":-4.858019,"twenty":-6.694902,"median":-5.775692,"eighty":-5.295379,"marketCap":394101947},{"date":"2024-06-21","current":-4.102454,"twenty":-6.686174,"median":-5.755637,"eighty":-5.203025,"marketCap":332807503},{"date":"2024-06-28","current":-3.825833,"twenty":-6.685159,"median":-5.743893,"eighty":-5.149649,"marketCap":310366874},{"date":"2024-07-05","current":-4.380219,"twenty":-6.677519,"median":-5.73799,"eighty":-4.872237,"marketCap":355340861},{"date":"2024-07-12","current":-5.240945,"twenty":-6.652589,"median":-5.708166,"eighty":-4.858612,"marketCap":425166453},{"date":"2024-07-15","current":-5.618156,"twenty":-6.652132,"median":-5.702159,"eighty":-4.859205,"marketCap":455767311},{"date":"2024-08-02","current":-4.971182,"twenty":-6.651675,"median":-5.698816,"eighty":-4.859798,"marketCap":403282204},{"date":"2024-08-09","current":-4.113885,"twenty":-6.640451,"median":-5.660935,"eighty":-4.773204,"marketCap":333734802},{"date":"2024-08-16","current":-4.916432,"twenty":-6.613212,"median":-5.643524,"eighty":-4.733343,"marketCap":419376556},{"date":"2024-08-23","current":-4.817231,"twenty":-6.59861,"median":-5.625283,"eighty":-4.733343,"marketCap":410914634},{"date":"2024-08-30","current":-5.446229,"twenty":-6.597297,"median":-5.604672,"eighty":-4.737935,"marketCap":464568797},{"date":"2024-09-06","current":-4.658074,"twenty":-6.575014,"median":-5.590187,"eighty":-4.732471,"marketCap":397338364},{"date":"2024-09-13","current":-4.408437,"twenty":-6.520293,"median":-5.578489,"eighty":-4.665342,"marketCap":376044078},{"date":"2024-09-20","current":-4.196954,"twenty":-6.477243,"median":-5.57069,"eighty":-4.6075,"marketCap":358004377},{"date":"2024-09-27","current":-3.78816,"twenty":-6.457997,"median":-5.564005,"eighty":-4.555487,"marketCap":323133821},{"date":"2024-10-04","current":-3.412069,"twenty":-6.444854,"median":-5.520554,"eighty":-4.463176,"marketCap":291052909},{"date":"2024-10-11","current":-3.984381,"twenty":-6.396267,"median":-5.495668,"eighty":-4.391506,"marketCap":339871688},{"date":"2024-10-18","current":-8.722034,"twenty":-6.444854,"median":-5.494185,"eighty":-4.372675,"marketCap":743998188},{"date":"2024-10-25","current":-7.426973,"twenty":-6.575014,"median":-5.518326,"eighty":-4.380219,"marketCap":633528265},{"date":"2024-10-31","current":-6.633368,"twenty":-6.626621,"median":-5.552864,"eighty":-4.385863,"marketCap":565832892},{"date":"2024-11-08","current":-7.532715,"twenty":-6.647324,"median":-5.570133,"eighty":-4.416277,"marketCap":642548116},{"date":"2024-11-15","current":-5.302508,"twenty":-6.677519,"median":-5.57069,"eighty":-4.447647,"marketCap":465602621},{"date":"2024-11-22","current":-5.400663,"twenty":-6.652589,"median":-5.56679,"eighty":-4.448989,"marketCap":474221422},{"date":"2024-11-29","current":-5.554297,"twenty":-6.650761,"median":-5.56679,"eighty":-4.454222,"marketCap":487711719},{"date":"2024-12-06","current":-4.173725,"twenty":-6.633578,"median":-5.554297,"eighty":-4.447681,"marketCap":366486409},{"date":"2024-12-13","current":-4.690106,"twenty":-6.633368,"median":-5.55038,"eighty":-4.454222,"marketCap":411828797},{"date":"2024-12-20","current":-4.600486,"twenty":-6.599635,"median":-5.518326,"eighty":-4.476607,"marketCap":403959457},{"date":"2024-12-27","current":-4.39564,"twenty":-6.598268,"median":-5.495668,"eighty":-4.47213,"marketCap":385972394},{"date":"2025-01-03","current":-4.376436,"twenty":-6.597297,"median":-5.489358,"eighty":-4.431958,"marketCap":384286107},{"date":"2025-01-10","current":-4.013689,"twenty":-6.580078,"median":-5.474874,"eighty":-4.400759,"marketCap":352434016},{"date":"2025-01-17","current":-3.945407,"twenty":-6.549815,"median":-5.463733,"eighty":-4.371161,"marketCap":346438328},{"date":"2025-01-24","current":-4.049964,"twenty":-6.531256,"median":-5.447319,"eighty":-4.329948,"marketCap":355619225},{"date":"2025-01-31","current":-3.646675,"twenty":-6.482324,"median":-5.400974,"eighty":-4.264567,"marketCap":320207195},{"date":"2025-02-07","current":-3.864323,"twenty":-6.459999,"median":-5.376271,"eighty":-4.20066,"marketCap":339318449},{"date":"2025-02-14","current":-3.102554,"twenty":-6.448423,"median":-5.308909,"eighty":-4.176092,"marketCap":272429058},{"date":"2025-02-21","current":-3.056677,"twenty":-6.434147,"median":-5.302508,"eighty":-4.119313,"marketCap":268400706},{"date":"2025-02-28","current":-2.638451,"twenty":-6.340126,"median":-5.244267,"eighty":-4.093707,"marketCap":231677119},{"date":"2025-03-07","current":-2.367458,"twenty":-6.339446,"median":-5.203025,"eighty":-4.06287,"marketCap":207881733},{"date":"2025-03-14","current":-2.630983,"twenty":-6.269217,"median":-5.198397,"eighty":-4.049964,"marketCap":231021340},{"date":"2025-03-21","current":-2.460092,"twenty":-6.255885,"median":-5.114065,"eighty":-3.984381,"marketCap":205616953},{"date":"2025-03-28","current":-2.06468,"twenty":-6.247779,"median":-5.067789,"eighty":-3.960398,"marketCap":172568018},{"date":"2025-04-04","current":-1.656911,"twenty":-6.240921,"median":-5.016723,"eighty":-3.945407,"marketCap":138486304},{"date":"2025-04-11","current":-1.456959,"twenty":-6.236945,"median":-4.994706,"eighty":-3.88409,"marketCap":121774058},{"date":"2025-04-17","current":-1.512002,"twenty":-6.221793,"median":-4.974969,"eighty":-3.861976,"marketCap":126374620},{"date":"2025-04-25","current":-1.959087,"twenty":-6.206418,"median":-4.916432,"eighty":-3.824403,"marketCap":163742450},{"date":"2025-05-02","current":-2.066365,"twenty":-6.177673,"median":-4.874702,"eighty":-3.775951,"marketCap":172708852},{"date":"2025-05-09","current":-1.654409,"twenty":-6.170108,"median":-4.860984,"eighty":-3.687236,"marketCap":144613576},{"date":"2025-05-16","current":-1.555575,"twenty":-6.148652,"median":-4.836663,"eighty":-3.631696,"marketCap":135974324},{"date":"2025-05-23","current":-1.591026,"twenty":-6.130879,"median":-4.78968,"eighty":-3.512031,"marketCap":139073186},{"date":"2025-05-30","current":-1.260144,"twenty":-6.108373,"median":-4.78372,"eighty":-3.223328,"marketCap":110150471},{"date":"2025-06-06","current":-1.32675,"twenty":-6.061356,"median":-4.749297,"eighty":-3.117918,"marketCap":115972576},{"date":"2025-06-13","current":-1.50186,"twenty":-6.034499,"median":-4.735087,"eighty":-2.776295,"marketCap":131279078},{"date":"2025-06-20","current":-1.338568,"twenty":-6.030043,"median":-4.699133,"eighty":-2.705652,"marketCap":117005530},{"date":"2025-06-27","current":-1.325676,"twenty":-6.018574,"median":-4.677957,"eighty":-2.666335,"marketCap":115878671},{"date":"2025-07-03","current":-1.43418,"twenty":-6.003199,"median":-4.660916,"eighty":-2.628422,"marketCap":125363068},{"date":"2025-07-11","current":-1.459963,"twenty":-5.99384,"median":-4.62319,"eighty":-2.383248,"marketCap":127616786},{"date":"2025-07-18","current":-1.485746,"twenty":-5.986149,"median":-4.615445,"eighty":-2.328623,"marketCap":129870504},{"date":"2025-07-25","current":-1.708124,"twenty":-5.970205,"median":-4.600486,"eighty":-2.093296,"marketCap":149308822},{"date":"2025-08-01","current":-1.607141,"twenty":-5.940584,"median":-4.57486,"eighty":-1.999527,"marketCap":140481760},{"date":"2025-08-08","current":-1.703827,"twenty":-5.922535,"median":-4.545683,"eighty":-1.959761,"marketCap":148933203},{"date":"2025-08-15","current":-2.043579,"twenty":-5.895837,"median":-4.518539,"eighty":-1.949427,"marketCap":186691151},{"date":"2025-08-22","current":-2.112452,"twenty":-5.862962,"median":-4.454222,"eighty":-1.956391,"marketCap":192983056},{"date":"2025-08-29","current":-2.433175,"twenty":-5.854715,"median":-4.430175,"eighty":-1.959087,"marketCap":222282674},{"date":"2025-09-05","current":-2.887018,"twenty":-5.836969,"median":-4.402038,"eighty":-1.959087,"marketCap":263743510},{"date":"2025-09-12","current":-3.535145,"twenty":-5.825985,"median":-4.380219,"eighty":-1.962457,"marketCap":322953154},{"date":"2025-09-19","current":-3.414874,"twenty":-5.825526,"median":-4.355835,"eighty":-1.96751,"marketCap":311965797},{"date":"2025-09-26","current":-3.921657,"twenty":-5.806571,"median":-4.328858,"eighty":-1.980874,"marketCap":358262949},{"date":"2025-10-03","current":-4.69982,"twenty":-5.793518,"median":-4.339167,"eighty":-1.984924,"marketCap":429352085},{"date":"2025-10-10","current":-4.804672,"twenty":-5.786833,"median":-4.376436,"eighty":-1.99391,"marketCap":438930806},{"date":"2025-10-17","current":-4.995872,"twenty":-5.775692,"median":-4.38793,"eighty":-1.995034,"marketCap":456397885},{"date":"2025-10-24","current":-3.854839,"twenty":-5.770184,"median":-4.380219,"eighty":-2.0175,"marketCap":352158862},{"date":"2025-10-31","current":-3.746904,"twenty":-5.755637,"median":-4.355835,"eighty":-2.027132,"marketCap":342298414},{"date":"2025-11-07","current":-3.348057,"twenty":-5.743893,"median":-4.33284,"eighty":-2.032103,"marketCap":305861710},{"date":"2025-11-14","current":-0.67005,"twenty":-5.739166,"median":-4.291871,"eighty":-2.032103,"marketCap":61212417},{"date":"2025-11-21","current":-0.637995,"twenty":-5.73799,"median":-4.263806,"eighty":-1.99391,"marketCap":56409597},{"date":"2025-11-28","current":-0.607107,"twenty":-5.724273,"median":-4.259855,"eighty":-1.966499,"marketCap":53678581},{"date":"2025-12-05","current":-0.725333,"twenty":-5.715508,"median":-4.21043,"eighty":-1.954144,"marketCap":64131778},{"date":"2025-12-12","current":-0.841429,"twenty":-5.70918,"median":-4.195844,"eighty":-1.830004,"marketCap":74396630},{"date":"2025-12-19","current":-0.832908,"twenty":-5.703313,"median":-4.178846,"eighty":-1.734551,"marketCap":73643246},{"date":"2025-12-26","current":-0.895749,"twenty":-5.698148,"median":-4.175072,"eighty":-1.71414,"marketCap":79199450},{"date":"2026-01-02","current":-0.853145,"twenty":-5.689788,"median":-4.172125,"eighty":-1.703182,"marketCap":75432532},{"date":"2026-01-09","current":-0.974567,"twenty":-5.676061,"median":-4.119313,"eighty":-1.677034,"marketCap":86168249},{"date":"2026-01-16","current":-0.937288,"twenty":-5.665333,"median":-4.107026,"eighty":-1.662811,"marketCap":82872196},{"date":"2026-01-23","current":-1.11942,"twenty":-5.660609,"median":-4.081971,"eighty":-1.645845,"marketCap":98975770},{"date":"2026-01-30","current":-1.417648,"twenty":-5.657347,"median":-4.065967,"eighty":-1.61564,"marketCap":125344196},{"date":"2026-02-06","current":-1.229125,"twenty":-5.647115,"median":-4.062285,"eighty":-1.591885,"marketCap":108675584},{"date":"2026-02-13","current":-1.252558,"twenty":-5.635533,"median":-4.060161,"eighty":-1.565529,"marketCap":110747389},{"date":"2026-02-20","current":-1.246167,"twenty":-5.627511,"median":-4.013689,"eighty":-1.532222,"marketCap":110182351},{"date":"2026-02-27","current":-1.288771,"twenty":-5.625283,"median":-3.995468,"eighty":-1.512002,"marketCap":113949269},{"date":"2026-03-06","current":-1.166285,"twenty":-5.618156,"median":-3.983816,"eighty":-1.485746,"marketCap":103119380},{"date":"2026-03-13","current":-1.41446,"twenty":-5.613028,"median":-3.964717,"eighty":-1.458888,"marketCap":165859566},{"date":"2026-03-20","current":-1.360341,"twenty":-5.596315,"median":-3.952659,"eighty":-1.456959,"marketCap":159513635},{"date":"2026-03-27","current":-1.341892,"twenty":-5.592973,"median":-3.946474,"eighty":-1.441232,"marketCap":157350249},{"date":"2026-04-02","current":-1.555906,"twenty":-5.588516,"median":-3.936144,"eighty":-1.433965,"marketCap":182445523},{"date":"2026-04-10","current":-1.608794,"twenty":-5.584425,"median":-3.915489,"eighty":-1.43418,"marketCap":188647228},{"date":"2026-04-17","current":-1.656763,"twenty":-5.581512,"median":-3.877823,"eighty":-1.439822,"marketCap":194272031},{"date":"2026-04-24","current":-1.672138,"twenty":-5.578985,"median":-3.864323,"eighty":-1.44213,"marketCap":196074852},{"date":"2026-05-01","current":-1.659223,"twenty":-5.57225,"median":-3.847212,"eighty":-1.447747,"marketCap":194560482},{"date":"2026-05-08","current":-1.637975,"twenty":-5.57069,"median":-3.825833,"eighty":-1.453492,"marketCap":185906940},{"date":"2026-05-15","current":-1.407973,"twenty":-5.57069,"median":-3.802332,"eighty":-1.44213,"marketCap":159802086},{"date":"2026-05-22","current":-1.423222,"twenty":-5.569799,"median":-3.779439,"eighty":-1.43289,"marketCap":161532795},{"date":"2026-05-29","current":-1.702783,"twenty":-5.566233,"median":-3.7619,"eighty":-1.43375,"marketCap":193262451},{"date":"2026-06-05","current":-1.42068,"twenty":-5.55818,"median":-3.729942,"eighty":-1.429524,"marketCap":161244343},{"date":"2026-06-12","current":-1.338082,"twenty":-5.554297,"median":-3.693618,"eighty":-1.420319,"marketCap":151869672},{"date":"2026-06-18","current":-1.404161,"twenty":-5.553724,"median":-3.650276,"eighty":-1.4185,"marketCap":159369409},{"date":"2026-06-26","current":-1.546483,"twenty":-5.550877,"median":-3.642613,"eighty":-1.420139,"marketCap":175522689},{"date":"2026-07-02","current":-1.734551,"twenty":-5.542873,"median":-3.618831,"eighty":-1.421188,"marketCap":196868094},{"date":"2026-07-10","current":-1.817149,"twenty":-5.521891,"median":-3.574125,"eighty":-1.423222,"marketCap":206242765},{"date":"2026-07-17","current":-1.560461,"twenty":-5.513869,"median":-3.523512,"eighty":-1.42373,"marketCap":177109171},{"date":"2026-07-24","current":-1.465156,"twenty":-5.495968,"median":-3.478607,"eighty":-1.427017,"marketCap":166292243},{"date":"2026-07-31","current":-1.327916,"twenty":-5.495668,"median":-3.414874,"eighty":-1.42068,"marketCap":150715866},{"date":"2026-08-07","current":-1.639113,"twenty":-5.492701,"median":-3.397655,"eighty":-1.419778,"marketCap":174801560},{"date":"2026-08-14","current":-1.835113,"twenty":-5.489358,"median":-3.353196,"eighty":-1.42068,"marketCap":195703835},{"date":"2026-08-21","current":-1.789546,"twenty":-5.477103,"median":-3.28218,"eighty":-1.423222,"marketCap":190844372},{"date":"2026-08-28","current":-1.830971,"twenty":-5.474874,"median":-3.222646,"eighty":-1.423222,"marketCap":195262065},{"date":"2026-09-04","current":-1.604516,"twenty":-5.469304,"median":-3.187547,"eighty":-1.425763,"marketCap":171112006},{"date":"2026-09-11","current":-1.803354,"twenty":-5.468413,"median":-3.15468,"eighty":-1.430777,"marketCap":192316936}],"updateTime":1789233545327},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KRRO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633008131","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: CareCloud (CCLD) and Korro Bio (KRRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633008131","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633008131?lang=en_us&edition=fundamental","pubTime":"2026-05-08 10:30","pubTimestamp":1778207426,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on CareCloud (CCLD) and Korro Bio (KRRO). CareCloud (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-carecloud-ccld-and-korro-bio-krro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-carecloud-ccld-and-korro-bio-krro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CCLD","BK4585","KRRO","BK4581","BK4137","BK4167","HCSG","LABU","XBI","BK4139","BK4588","LU0029874061.USD","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633122951","title":"Korro Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633122951","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633122951?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:51","pubTimestamp":1778172670,"startTime":"0","endTime":"0","summary":"Korro Bio Inc reports results for the quarter ended March 31 - Earnings SummaryKorro Bio Inc KRRO.OQ reported a quarterly adjusted loss of $1.69 per share for the quarter ended March 31, higher than t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K2LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633142157","title":"Korro Bio Q1 EPS $(1.69) Beats $(2.17) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142157","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633142157?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:30","pubTimestamp":1778157033,"startTime":"0","endTime":"0","summary":"Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(1.69) per share which beat the analyst consensus estimate of $(2.17) by 22.12 percent. This is a 32.13 percent increase over losses of $(2.49) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52364185/korro-bio-q1-eps-1-69-beats-2-17-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633464461","title":"Korro Bio posts corporate presentation on RNA-editing genetic medicines pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633464461","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633464461?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:21","pubTimestamp":1778152893,"startTime":"0","endTime":"0","summary":"Korro Bio outlined 2026 milestones led by an anticipated H2 2026 regulatory filing for lead program KRRO-121 in hyperammonemia.Development candidate selection expected in Q2 2026 for a GalNAc-conjugated RNA-editing program in alpha-1 antitrypsin deficiency.Another development candidate for a third GalNAc-conjugated liver asset targeted for H2 2026, alongside continued work on liver longevity and an intrathecal ALS program.Cash, cash equivalents, and marketable securities totaled USD 157.1 million as of March 31, 2025, with runway projected into H2 2028.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLbyCH0D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145159","title":"Korro Bio Q1 FY26 net loss narrows to $19.6 million; R&D expenses fall to $12.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145159","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633145159?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:08","pubTimestamp":1778152090,"startTime":"0","endTime":"0","summary":"Korro Bio posted a net loss of $19.6 million, or $1.69 per share, for first-quarter 2026, narrowing from a $23.4 million loss a year earlier.Operating loss narrowed to $20.4 million from $25 million, while revenue swung to no collaboration revenue from $2.6 million on a 12-month pause of its Novo Nordisk collaboration agreed in November 2025.R&D expense fell to $13 million from $19.7 million, while G&A expense edged down to $7.5 million from $7.8 million.Cash, cash equivalents, and marketable securities rose to $157.1 million from $85.2 million at year-end 2025, following an oversubscribed $85 million private placement that Korro expects will extend runway into second-half 2028.KRRO-121 regulatory filing remains targeted for second-half 2026, while a development candidate for its GalNAc alpha-1 antitrypsin deficiency program is expected in second-quarter 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL1s4vGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","SG9999014039.USD","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","BK4139","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","KRRO","IE00BGHQF748.EUR","NDAQ","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633478491","title":"Korro Bio Inc Qtrly EPS $-1.69","url":"https://stock-news.laohu8.com/highlight/detail?id=2633478491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633478491?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA6BKCTT:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633214788","title":"Korro Bio Inc - Reports Cash, Cash Equivalents and Marketable Securities of $157.1 Mln as of March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633214788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633214788?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA6BKCTT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633147887","title":"Korro Bio Inc - Reports No Collaboration Revenue for Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633147887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633147887?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA6BKCTT:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633147880","title":"Korro Bio Inc - Expects Cash Position to Fund Operations Into Second Half of 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2633147880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633147880?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA6BKCTT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633929011","title":"Korro Bio participates in HCW BioConnect Nasdaq investor conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2633929011","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633929011?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:18","pubTimestamp":1778012327,"startTime":"0","endTime":"0","summary":"Korro Bio executives scheduled to appear at HCW 4th Annual BioConnect Nasdaq Investor Conference on May 19, 2026 at 4:00 p.m. ET.Fireside chat set for 2026 RBC Capital Markets Global Healthcare Conference on May 20, 2026 at 11:30 a.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL8K1z1n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2W23.USD","NDAQ","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4139","LU2210150020.SGD","BK4112","SG9999014013.SGD","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632118366","title":"Korro Bio Inc  expected to post a loss of $1.84 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632118366","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632118366?lang=en_us&edition=fundamental","pubTime":"2026-05-01 19:26","pubTimestamp":1777634769,"startTime":"0","endTime":"0","summary":"Korro Bio Inc  expected to post a loss of $1.84 a share - Earnings Preview Korro Bio Inc KRRO.OQ KRRO.O is expected to  show a fall in quarterly revenue when it reports  results on May 5 (estimated) f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL8N41E0N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627297553","title":"Korro Bio to present preclinical KRRO-121 hyperammonemia data at ASGCT meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2627297553","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627297553?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:34","pubTimestamp":1776339282,"startTime":"0","endTime":"0","summary":"Korro Bio flagged upcoming scientific conference presentations that highlight preclinical data for KRRO-121, an RNA-editing oligonucleotide being developed for hyperammonemia.Data will be presented in future sessions at ASGCT on May 14 and at Ureagenesis Defects conference on April 24.Management plans to outline findings indicating KRRO-121 produced strong ammonia clearance in multiple preclinical model systems.Separate ASGCT presentation on May 15 will preview preclinical results showing RNA editing restored Alpha-1 Antitrypsin function in models of Alpha-1 Antitrypsin Deficiency.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief on April 16, 2026, and is sole","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL6CN9sd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627860297","title":"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2627860297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627860297?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:30","pubTimestamp":1776339001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUA4KGND0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627294710","title":"Korro Bio announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2627294710","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627294710?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:01","pubTimestamp":1776337297,"startTime":"0","endTime":"0","summary":"Korro Bio scheduled 2026 annual shareholder meeting to be held online June 10, 2026.Shareholders will vote on election of two Class I directors: Nessan Bermingham, Rachel Meyers.Meeting agenda includes advisory vote on named executive officer compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL6h7NVx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626801148","title":"BRIEF-Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626801148","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626801148?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:19","pubTimestamp":1775852364,"startTime":"0","endTime":"0","summary":"BRIEF-Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)April 10 (Reuters) - Korro Bio Inc KRRO.O:KORRO BIO REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nGNX2zcH0MFurther company coverage: KRRO.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nTUA7PV4RY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626811042","title":"Korro Bio grants new-hire inducement option for 15,000 shares at $13.46 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2626811042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626811042?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:05","pubTimestamp":1775851519,"startTime":"0","endTime":"0","summary":"Korro Bio granted a nonstatutory stock option covering 15,000 common shares to one newly hired employee.Exercise price set at $13.46 per share, based on Nasdaq closing price on April 8, 2026.Vesting schedule spans four years, with 25% vesting on first anniversary of employee start date.Remaining 75% vests in 36 equal monthly installments through fourth anniversary of start date.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL26Yf5k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","SG9999014013.SGD","SG9999014021.USD","BK4588","LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4139","NDAQ","KRRO","LU2095319765.USD","BK4112","IE00BKPKM429.USD","SG9999014039.USD","BK4585","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624683589","title":"Korro Bio initial beneficial ownership filing shows Lynx1 Capital Management as 10% owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2624683589","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624683589?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:01","pubTimestamp":1775145684,"startTime":"0","endTime":"0","summary":"Lynx1 Capital Management reported beneficial ownership of 1,537,776 Korro Bio common shares.Filing identified Lynx1 Capital Management as a 10% owner, citing an event date of March 31, 2026.Weston Nichols was listed as a reporting person in the Form 3 filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL6dyctJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620822229","title":"Korro Bio Inc. publishes corporate presentation on RNA editing genetic medicines and pipeline milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2620822229","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620822229?lang=en_us&edition=fundamental","pubTime":"2026-03-20 00:06","pubTimestamp":1773936368,"startTime":"0","endTime":"0","summary":"Korro outlined plans to develop RNA-editing medicines that modify RNA without permanently changing DNA, with a focus on rare and prevalent diseases.A development candidate is expected in Q2 2026 for a GalNAc-conjugated construct targeting alpha-1 antitrypsin deficiency, and another GalNAc-conjugated liver asset is expected to reach development-candidate stage in H2 2026.Cash, cash equivalents and marketable securities were reported at USD 85.2 million as of December 31, 2025.The presentation described KRRO-121 as a GalNAc-conjugated oligonucleotide designed for liver-specific RNA editing of glutamine synthetase to enhance ammonia clearance capacity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL16GynJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619466984","title":"Korro Bio Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2619466984","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619466984?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:31","pubTimestamp":1773667901,"startTime":"0","endTime":"0","summary":"Korro Bio Inc reports results for the quarter ended December 31 - Earnings SummaryKorro Bio Inc KRRO.OQ reported a quarterly adjusted loss of $1.65 per share for the quarter ended December 31, higher ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL8N4041AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}